(1) Background: Norepinephrine (NE) is the first-line vasoactive agent used in septic shock patients; however, the effect of norepinephrine on dialysis-required septic acute kidney injury (AKI-D) patients is uncertain. (2) Methods: To evaluate the impact of NE on 90-day mortality and renal recovery in septic AKI-D patients, we enrolled patients in intensive care units from 30 hospitals in Taiwan. (3) Results: 372 patients were enrolled and were divided into norepinephrine users and non-users. After adjustment by Inverse probability of treatment weighted (IPTW), there was no significant difference of baseline comorbidities between the two groups. NE users had significantly higher 90-day mortality rate and using NE is a strong predictor of 90-day mortality in the multivariate Cox regression (HR = 1.497, p = 0.027) after adjustment. The generalized additive model disclosed norepinephrine alone exerted a dose–dependent effect on 90-day mortality, while other vasoactive agents were not. (4) Conclusion: Using norepinephrine in septic AKI-D patients is associated with higher 90-day mortality and the effect is dose-dependent. Further study to explore the potential mechanism is needed.

Original languageEnglish
Article number274
JournalJournal of Clinical Medicine
Issue number9
Publication statusPublished - Sept 12 2018


  • Acute kidney injury
  • Critical care
  • Dialysis
  • Norepinephrine
  • Sepsis
  • Vasoactive agents

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Norepinephrine administration is associated with higher mortality in dialysis requiring acute kidney injury patients with septic shock'. Together they form a unique fingerprint.

Cite this